Hi — I started PrivateTechShares because too many people hold startup equity they don't fully understand and aren't sure what to do with. This is a place for employees and founders to talk it through: exercising, selling, lock-ups, taxes, tenders. Ask the question you're not sure how to ask. Share what worked. Help the next person who's where you were a year ago.
— P., PrivateTechShares
House rules — keep it open and friendly. Questions about buying, selling, how and where are all welcome, and so is sharing your own experience. The only no-go is solicitation or sales on the forum itself: no offers to buy or sell shares, no advertising, no promoting funds, brokers or deals. Experience & education, not financial advice.
How it runs: anyone can post a question or answer any topic — no login, no email. It's self-running; admins only step in to remove rude or soliciting posts.
Real questions from people who hold startup equity, each with a short answer. Join the live discussion or add your own question below.
The big ones: the company's right of first refusal (ROFR), board approval, co-sale rights, and outright transfer bans. The ROFR is where most sales stall. Read the transfer section first.
The buyer can assume them, accelerate them (single- or double-trigger), or cancel them. Your plan's change-of-control clause decides, so read it before any deal closes.
Depends on the deal: vested options are typically cashed out (value minus strike) or rolled into the buyer's equity; the merger agreement sets the terms. Watch in-the-money vs underwater.
Not on day one — a lock-up (often 90-180 days) usually blocks sales after the IPO, and your options still need exercising into shares first. After the lock-up lifts you sell through a brokerage.
Unvested equity simply doesn't become yours — you keep only what has vested by your last day, and the rest returns to the pool. Check your cliff and vesting schedule before you resign.
If the company shuts down, unvested (and usually vested) equity typically becomes worthless — common stock sits last in the stack. It's the hard truth of concentration risk.
ISOs can get capital-gains treatment if you meet the holding periods but may trigger AMT at exercise. NSOs are taxed as ordinary income on the spread at exercise. Which you hold changes the whole plan.
It can be huge — if your shares qualify, QSBS can exempt a large chunk of the gain from federal tax after a 5-year hold. The qualifying tests are strict, so check them early.
A higher round price means the company raises the same money for fewer new shares — so your percentage is diluted less. But headline valuation isn't the whole story; terms matter too.
Exercising ISOs adds the paper spread to AMT income, so you can owe tax before selling. Levers: exercise early when the spread is tiny, or split exercises across tax years to stay under the AMT line.
That figure usually multiplies your options by a notional share price — it's potential, not cash. Subtract the strike, taxes, dilution and the risk the exit never comes to gauge real value.
Vested options are usually yours to exercise — but only within a post-termination window (often 90 days), after which they expire. Know that deadline before you hand in notice.
There's generally no late 83(b) — the 30-day window is hard. If you missed it you're taxed as shares vest instead of at grant, which hurts if value climbs; model it before your next exercise.
The cash to exercise plus the tax can be brutal. Options: exercise only vested/early when the spread is small, a cashless or company-tender route, or exercise-and-sell-to-cover where allowed.
A judgement call: take enough off the table to cover taxes plus a cushion, without betting everything on one illiquid stock that may never IPO. A waterfall model shows what you'd net at different prices.